Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Regeneron Pharmaceuticals
REGN
$69.9B
| $131M | 0.14% |
349,862
+81,800
| +31% | +$29.9M |
|
|
RTN
152
DELISTED
Raytheon Company
RTN
| $130M | 0.14% |
+844,600
| New | +$151M |
|
153
Mastercard
MA
$487B
| $129M | 0.14% |
684,444
+20,444
| +3% | +$4.06M |
|
|
CCMP
154
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $126M | 0.14% |
1,324,066
+65,257
| +5% | +$6.4M |
|
155
Douglas Emmett
DEI
$2.03B
| $126M | 0.14% |
3,694,200
+169,300
| +5% | +$6.08M |
|
|
GHDX
156
DELISTED
Genomic Health, Inc.
GHDX
| $125M | 0.14% |
1,947,100
+164,000
| +9% | +$11.5M |
|
157
BCE
BCE
$19.8B
| $125M | 0.14% |
3,171,498
-452,473
| -12% | -$18.5M |
|
158
Medifast
MED
$110M
| $124M | 0.14% |
990,000
+31,600
| +3% | +$5.41M |
|
159
Enterprise Products Partners
EPD
$82.5B
| $123M | 0.13% |
5,011,149
+3,925,100
| +361% | +$105M |
|
|
MZTI
160
The Marzetti Company
MZTI
$2.95B
| $123M | 0.13% |
696,400
-22,362
| -3% | -$3.81M |
|
161
AGNC Investment
AGNC
$12.4B
| $122M | 0.13% |
6,981,929
+3,031,800
| +77% | +$54M |
|
162
PVH
PVH
$3.87B
| $121M | 0.13% |
1,301,345
+1,142,345
| +718% | +$131M |
|
163
Philip Morris
PM
$305B
| $119M | 0.13% |
1,789,400
+1,104,400
| +161% | +$92.2M |
|
164
Diageo
DEO
$47.3B
| $119M | 0.13% |
841,900
+55,600
| +7% | +$7.82M |
|
|
HZNP
165
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $119M | 0.13% |
6,066,275
+45,700
| +0.8% | +$896K |
|
166
Accenture
ACN
$94.3B
| $118M | 0.13% |
838,400
+564,700
| +206% | +$89.3M |
|
167
NVIDIA
NVDA
$4.76T
| $117M | 0.13% |
35,175,720
-48,482,880
| -58% | -$232M |
|
168
DexCom
DXCM
$28.3B
| $117M | 0.13% |
3,898,352
+1,566,116
| +67% | +$49.7M |
|
169
Exelixis
EXEL
$14B
| $116M | 0.13% |
5,919,727
+1,821,017
| +44% | +$32.5M |
|
170
Ecopetrol
EC
$32.5B
| $116M | 0.13% |
7,304,100
-278,424
| -4% | -$5.97M |
|
171
Chunghwa Telecom
CHT
$33.4B
| $116M | 0.13% |
3,240,692
+30,344
| +0.9% | +$1.06M |
|
172
HEICO Corp Class A
HEI.A
$36.3B
| $116M | 0.13% |
1,835,645
-26,407
| -1% | -$1.77M |
|
173
Altria Group
MO
$122B
| $115M | 0.13% |
2,334,800
+1,604,155
| +220% | +$92.9M |
|
174
FirstCash
FCFS
$9.06B
| $115M | 0.13% |
1,584,424
+91,800
| +6% | +$7.32M |
|
|
TRCO
175
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $115M | 0.13% |
2,524,100
+1,452,700
| +136% | +$58.8M |
|
Similar funds
Renaissance Technologies's Q4 2018 Portfolio in Review
As of Q4 2018, Renaissance Technologies held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Renaissance Technologies's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Renaissance Technologies's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Renaissance Technologies fully exited Danaher in Q4 2018, selling an estimated $350M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Renaissance Technologies opened 522 new positions and closed 504 in Q4 2018.
- Renaissance Technologies's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.